161 related articles for article (PubMed ID: 37423628)
1. Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using
Tallon EM; Gallagher MP; Staggs VS; Ferro D; Murthy DB; Ebekozien O; Kosiborod MN; Lind M; Manrique-Acevedo C; Shyu CR; Clements MA
BMJ Open; 2023 Jul; 13(7):e071475. PubMed ID: 37423628
[TBL] [Abstract][Full Text] [Related]
2. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L
J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
[TBL] [Abstract][Full Text] [Related]
4. Children, adolescents, and young adults hospitalized with COVID-19 and diabetes in summer 2021.
Agathis NT; Womack LS; Webber BJ; Choudhary R; Wanga V; Ko JY; Dupont H; Imperatore G; Koumans EH; Saydah S; Kimball AA; Siegel DA;
Pediatr Diabetes; 2022 Nov; 23(7):961-967. PubMed ID: 35876454
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.
Tallon EM; Ebekozien O; Sanchez J; Staggs VS; Ferro D; McDonough R; Demeterco-Berggren C; Polsky S; Gomez P; Patel N; Prahalad P; Odugbesan O; Mathias P; Lee JM; Smith C; Shyu CR; Clements MA
Diabetes Res Clin Pract; 2022 Dec; 194():110156. PubMed ID: 36400172
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.
Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N
Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109
[TBL] [Abstract][Full Text] [Related]
7. Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study.
Mariet AS; Petit JM; Benzenine E; Quantin C; Bouillet B
Diabetes Metab; 2023 May; 49(3):101425. PubMed ID: 36669680
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.
Wang SY; Andrews CA; Herman WH; Gardner TW; Stein JD
Ophthalmology; 2017 Apr; 124(4):424-430. PubMed ID: 27914837
[TBL] [Abstract][Full Text] [Related]
9. Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus.
Pleniceanu O; Twig G; Tzur D; Gruber N; Stern-Zimmer M; Afek A; Erlich T; Keinan-Boker L; Skorecki K; Calderon-Margalit R; Vivante A
Pediatr Nephrol; 2021 Feb; 36(2):333-340. PubMed ID: 32761484
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
11. Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention.
Matetic A; Doolub G; Bharadwaj A; Osman M; Biondi-Zoccai G; Ullah W; Bagur R; Velagapudi P; Alraies MC; Mohamed MO; Mamas MA
Cardiovasc Revasc Med; 2022 May; 38():83-88. PubMed ID: 34446373
[TBL] [Abstract][Full Text] [Related]
12. Early experience with arterial thromboembolic complications in patients with COVID-19.
Indes JE; Koleilat I; Hatch AN; Choinski K; Jones DB; Aldailami H; Billett H; Denesopolis JM; Lipsitz E
J Vasc Surg; 2021 Feb; 73(2):381-389.e1. PubMed ID: 32861865
[TBL] [Abstract][Full Text] [Related]
13. Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in the U.S.
Barrett CE; Park J; Kompaniyets L; Baggs J; Cheng YJ; Zhang P; Imperatore G; Pavkov ME
Diabetes Care; 2021 Aug; 44(8):1788-1796. PubMed ID: 34158365
[TBL] [Abstract][Full Text] [Related]
14. Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study.
Carey IM; Critchley JA; DeWilde S; Harris T; Hosking FJ; Cook DG
Diabetes Care; 2018 Mar; 41(3):513-521. PubMed ID: 29330152
[TBL] [Abstract][Full Text] [Related]
15. Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study.
Demirci I; Haymana C; Tasci I; Satman I; Atmaca A; Sahin M; Ata N; Unluturk U; Cakal E; Dagdelen S; Sahin I; Celik O; Ertugrul D; Demir T; Emral R; Caglayan M; Salman S; Birinci S; Sonmez A
Endokrynol Pol; 2022; 73(1):87-95. PubMed ID: 35119089
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.
Calvisi SL; Ramirez GA; Scavini M; Da Prat V; Di Lucca G; Laurenzi A; Gallina G; Cavallo L; Borio G; Farolfi F; Pascali M; Castellani J; Lampasona V; D'Angelo A; Landoni G; Ciceri F; Querini PR; Tresoldi M; Piemonti L
Metabolism; 2021 Oct; 123():154845. PubMed ID: 34364927
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.
Ward A; Sarraju A; Lee D; Bhasin K; Gad S; Beetel R; Chang S; Bonafede M; Rodriguez F; Dash R
PLoS One; 2022; 17(1):e0261786. PubMed ID: 35020742
[TBL] [Abstract][Full Text] [Related]
18. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
[TBL] [Abstract][Full Text] [Related]
19. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
20. Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with diabetic ketoacidosis: a review and a propensity-matched nationwide analysis.
Shaka H; Wani F; El-Amir Z; Dahiya DS; Singh J; Edigin E; Eseaton P; Kichloo A
J Investig Med; 2021 Aug; 69(6):1196-1200. PubMed ID: 33972382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
